Hadas Weinstein-Marom is Scientific Co-founder of GentiBio and member of its scientific advisory board. She is a senior scientist at the Immunology Laboratory of MIGAL – Galilee Research Institute and a lecturer in the Biotechnology Department at Tel-Hai College. In the field of immuno-gene therapy of cancer, her research focuses on improving the selectivity and safety of adoptive T cell therapy and on enhancing the functional properties and survival of antitumor T cells. In the field of inflammatory diseases, her research focus is on genetically engineering regulatory T cells as a new tool for immunotherapy. Hadas received her B.Sc. in life sciences, M.Sc. in biotechnology-immunology, and Ph.D. in cancer immunotherapy, all from the Hebrew University of Jerusalem. She conducted her postdoctoral research with the Ella Lemelbaum Institute for Immuno-Oncology at the Sheba Medical Center and Tel Aviv University.
Hadas Weinstein-Marom, PhD
Senior Scientist & Lecturer, MIGAL, Scientific Co-Founder
